SCHEMBL130488

SCHEMBL130488

C=CC(O)C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1471843 1.00
SCHEMBL8764246 1.00 UGT2B7 (0.32)
SCHEMBL1464686 0.88
SCHEMBL7802318 0.88 UGT2B7 (0.31)
SCHEMBL10524293 0.86 TP53 (0.41)
SCHEMBL2511775 0.86 TP53 (0.41)
SCHEMBL15203259 0.83 SHBG (0.35)
SCHEMBL8718770 0.82 ALDH1A1 (0.38)
SCHEMBL6112257 0.82
SCHEMBL7586183 0.82 CPN1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050119241-A1 Preparation of 24 alkyl analogs of cholecalciferol and non-racemic compounds INSTYTUT FARMACEUTYCZNY (PL) 2005-06-02 US claimed
EP-1497264-A2 PREPARATION OF 24-ALKYL ANALOGS OF CHOLECALCIFEROL AND NON-RACEMIC COMPOUNDS INSTYTUT FARMACEUTYCZNY (PL) 2005-01-19 EP claimed
WO-2003087048-A2 PREPARATION OF 24 ALKYL ANALOGS OF CHOLECALCIFEROL AND NON-RACEMIC COMPOUNDS INSTYTUT FARMACEUTYCZNY (PL) 2003-10-23 WO claimed
WO-2014168262-A1 KINASE INHIBITORS CONTAINING CYCLOPROPANE SKELETON D.D.P. CORPORATION (JP) 2014-10-16 WO disclosed
US-8450319-B2 Pyrrolopyridazinone compound UBE INDUSTRIES, LTD. (JP) 2013-05-28 US disclosed
CN-102911041-A Photostable cis 2, 3-cyclopropanated abscisic acid analogue and preparation method thereof UNIV CHINA AGRICULTURAL 2013-02-06 CN disclosed
EP-1982986-B1 PYRROLOPYRIDAZINONE COMPOUND AS PDE4 INHIBITOR UBE INDUSTRIES (JP) 2012-03-07 EP disclosed
US-20110268698-A1 METHODS FOR TREATING HEPATITIS C PTC THERAPEUTICS, INC. (US) 2011-11-03 US disclosed
US-7915241-B2 Reacting a sulfone intermediate, possessing a (5E) or (5Z) configuration with an aldehyde having an (R) or an (S) configuration in the presence of a strong base, in an aprotic solvent; synthetic analog of vitamin D3-calcipotriol, biologically active compound used in medical treatment INSTYTUT FARMACEUTYCZNY (PL) 2011-03-29 US disclosed
US-20090036453-A1 Pyrrolopyridazinone Compound UBE INDUSTRIES, LTD. (JP) 2009-02-05 US disclosed
EP-1982986-A1 PYRROLOPYRIDAZINONE COMPOUND Ube Industries, Ltd. (JP) 2008-10-22 EP disclosed
US-20070088007-A1 Method for preparing analogue of vitamin D FORMOSA LABORATORIES, INC. (TW) 2007-04-19 US disclosed
US-20070088007-A1 Method for preparing analogue of vitamin D FORMOSA LABORATORIES, INC. (TW) 2007-04-19 US disclosed
US-20050119241-A1 Preparation of 24 alkyl analogs of cholecalciferol and non-racemic compounds INSTYTUT FARMACEUTYCZNY (PL) 2005-06-02 US disclosed
EP-1497264-A2 PREPARATION OF 24-ALKYL ANALOGS OF CHOLECALCIFEROL AND NON-RACEMIC COMPOUNDS INSTYTUT FARMACEUTYCZNY (PL) 2005-01-19 EP disclosed
WO-2003087048-A2 PREPARATION OF 24 ALKYL ANALOGS OF CHOLECALCIFEROL AND NON-RACEMIC COMPOUNDS INSTYTUT FARMACEUTYCZNY (PL) 2003-10-23 WO disclosed
US-4500541-A Pharmacologically active cyclopropane derivatives MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1985-02-19 US disclosed
EP-0039771-B1 CYCLOPROPANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THEIR PRODUCTION MERCK PATENT GmbH (DE) 1983-10-19 EP disclosed
EP-0039771-A1 Cyclopropane derivatives, pharmaceutical compositions containing them and processes for their production MERCK PATENT GmbH (DE) 1981-11-18 EP disclosed